Response Inhibition Training for Children With Williams Syndrome
NCT02212314, Not applicable, Completed, University of Wisconsin, Milwaukee
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Response Inhibition Training for Children With Williams Syndrome | ClinicalTrials.gov |
| NCT number | NCT02212314 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 25 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Wisconsin, Milwaukee | ClinicalTrials.gov |
| Conditions | Williams Syndrome | ClinicalTrials.gov |
| Interventions | Response Inhibition Training | ClinicalTrials.gov |
| First posted | 2014-08-08 | ClinicalTrials.gov |
| Last updated | 2017-05-31 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Cognitive Inhibition Tasks | 5-7 weeks and 3 months | Three measures of response inhibition that were administered to children at pre-test will be administered after the 5-7-week training and again at a 3-month follow-up. Measures include computer-administered Motor Stroop task, Stop Signal task, and Go/No-Go Task. | ClinicalTrials.gov |
| Secondary | Conners-3 | 5-7 weeks and 3 months | The Conners-3 will be administered to parents at post-intervention and again at follow-up to assess changes in attention and impulsivity. | ClinicalTrials.gov |
| Secondary | Emotion Regulation Checklist | 5-7 weeks and 3 months | The Emotion Regulation Checklist will be administered to parents at post-intervention and follow-up to assess changes in the child's ability to regulate emotions. | ClinicalTrials.gov |
| Secondary | Positive and Negative Affect Scale | 5-7 weeks and 3 months | The PANAS will be administered to parents at post-intervention and follow-up to assess changes in child positive and negative affect. | ClinicalTrials.gov |
| Secondary | Question-Asking Questionnaire | 5-7 weeks and 3 months | The QAQ will be administered to parents at post-intervention and follow-up to assess changes in amount and frequency of child anticipatory question asking. | ClinicalTrials.gov |
| Secondary | Spence Children's Anxiety Scale | 5-7 weeks, 3 months | The SCAS will be administered to parents at post-intervention and follow-up to assess changes in child anxieties. | ClinicalTrials.gov |
| Secondary | MINI Kid 6.0 Parent Version | 5-7 weeks and 3 months | The MINI Kid 6.0 Parent will be administered to parents at post-intervention and follow-up to assess changes in those areas endorsed at pre-intervention. | ClinicalTrials.gov |
| Other | Treatment Acceptability Questionnaire | 5-7 weeks | Questionnaire about study acceptability will be administered at post test after the 5-7 week training. | ClinicalTrials.gov |
| Other | Treatment Evaluation Inventory | 5-7 weeks | Questionnaire evaluating treatment will be administered at post test after the 5-7 week training. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Primary outcome | ConductCognition |
| Stop-Signal Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)